RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020 – GlobeNewswire
Posted: October 23, 2020 at 1:58 pm
RenovaCare Commences Investor Presentations
RenovaCare Commences Investor Presentations; Webcast on October 29, 2020 at 11:00 AM EDT
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; http://www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company will begin presenting business and financial updates, with the first scheduled for October 29, 2020 at 11:00 a.m. (EDT), to be held via online webcast.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3ab4ca73-7a9f-44f3-93f7-c2dd50571f3a
During the webcast, RenovaCare management will provide an overview of the Companys performance in 2020 year-to-date and also discuss its business objectives for 2021.
Interested investors, analysts and media representatives are invited to participate in the webcast via the following link:
Link to Register for RenovaCare Oct. 29, 2020 Investor Presentationhttps://edge.media-server.com/mmc/go/RenovaCare10292020
As investor engagement is important to RenovaCare, all interested parties will have the opportunity to ask questions by submitting them to investor_relations@renovacareinc.comby 3:30 p.m. eastern daylight time on October 28, 2020. Shareholders will also have the ability to ask questions during and following the presentation through a chat box with the presentation operator.
The webcast will be recorded and available for playback after the meeting through the RenovaCare website atwww.renovacareinc.com.
RenovaCarepatented investigative technologies are currently in development. They are not available for sale in the United States or elsewhere. There is no assurance that the Companys planned or filed submissions to the U.S. Food and Drug Administration or other regulatory authorities will be accepted or cleared.
About RenovaCareRenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the bodys largest organ, the skin. The companys flagship technology, the CellMist System, uses its patented SkinGun to spray a liquid suspension of a patients stem cells the CellMist Solution onto wounds.
Over 70 patients with various types of second-degree burns have been treated on an experimental basis utilizing the technology underlying the Companys SkinGun, which RenovaCare has developed as a potential alternative to skin grafting and other treatment options. Sprayed with a gentle mist of their own skin cells, many of these patients left the hospital within days, avoiding generally painful skin graft surgeries and potentially prolonged hospitalization.
RenovaCare is developing its CellMist System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars.
For additional information, please call Amit Singh at: 888-398-0202 or visit:https://renovacareinc.com
To receive future press releases via email, please visit:https://renovacareinc.com/investors/register/
Follow us on LinkedIn:https://www.linkedin.com/company/renovacare-inc-/Follow us on Twitter:https://twitter.com/RenovaCareIncFollow us on Facebook:https://www.facebook.com/renovacarercar
Social Media DisclaimerInvestors and others should note that we announce material financial information to our investors using SEC filings and press releases. We use our website and social media to communicate with our subscribers, shareholders and the public about the company, RenovaCare, Inc. development, and other corporate matters that are in the public domain. At this time, the company will not post information on social media that could be deemed to be material information unless that information was distributed to public distribution channels first. We encourage investors, the media, and others interested in the company to review the information we post on the companys website and the social media channels listed below:
* This list may be updated from time to time.
Legal Notice Regarding Forward-Looking StatementsNo statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although RenovaCare, Inc. (the Company) believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words may, will, should, could, expect, anticipate, estimate, believe, intend, or project or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: the timing and success of clinical and preclinical studies of product candidates, the potential timing and success of the Companys product programs through their individual product development and regulatory approval processes, adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, obsolescence of the Companys technologies, technical problems with the Companys research, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Companys operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Companys ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, and other risks. There can be no assurance that further research and development will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that the Company will be able to develop commercially viable products on the basis of its technologies. In addition, other factors that could cause actual results to differ materially are discussed in the Companys most recent Form 10-Q and Form 10-K filings with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission athttp://www.sec.gov. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Continue reading here:
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020 - GlobeNewswire
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now - February 9th, 2021
- Leukemia in children: Symptoms, causes, treatment, outlook, and more - Medical News Today - February 9th, 2021
- Paragon Biosciences Expands Cell And Gene Therapy Platform - Contract Pharma - February 9th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 9th, 2021
- Two Studies Shed Light on How and Where the Body Can Add New Fat Cells - Technology Networks - February 4th, 2021
- Heidi Klum loves to pamper her skin with goodies from Drunk Elephant and Glossier - woman&home - February 4th, 2021
- When to take fish oil: Timing, dosages and side effects - Medical News Today - February 4th, 2021
- Heidi Klum loves to pamper her skin with goodies from Drunk Elephant and Glossier - Woman & Home - February 3rd, 2021
- Paragon Biosciences Launches CiRC Biosciences to Expand Cell and Gene Therapy Platform - PRNewswire - February 3rd, 2021
- Amazon just slashed up to 60 percent off this top-rated skincare brand but only for today - Yahoo Sports - February 3rd, 2021
- Valentina Greco Receives the 2021 ISSCR Momentum Award < Yale School of Medicine - Yale School of Medicine - January 29th, 2021
- Love Your Skin: What Is SPF And Why Is It Important? - Yahoo Movies Canada - January 29th, 2021
- ToolGen ties up with 3D bioprinting company to apply induced pluripotent stem cells to gene correction - Aju Business Daily - January 29th, 2021
- Opdivo Side Effects: What They Are and How to Manage Them - Healthline - January 29th, 2021
- Why Hair Goes Gray, and How to Cover It If You Want To - NewBeauty Magazine - January 29th, 2021
- Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus - PRNewswire - January 29th, 2021
- How to Treat a Wounded Manatee - The New York Times - January 29th, 2021
- Research finds new proof about the systems controlling skin repair and regeneration - Microbioz India - January 23rd, 2021
- 4 Doctors Reveal the Pros and Cons to Microneedling Treatments - NewBeauty Magazine - January 23rd, 2021
- Here's Why The Body Shop Is A Cult Brand to Know Plus The Best-Sellers To Buy - GLAMOUR UK - January 23rd, 2021
- Ohio State establishing national standards for ALS genetic testing, research and patient care | Ohio State Medical Center - Wexner Medical Center -... - January 23rd, 2021
- Plant Stem Cell Market- Growth Opportunities by Manufacturers, Regions, Type and Application; Trends Forecast to 2026 | Coherent Market Insights - The... - January 23rd, 2021
- Global Regenerative Medicine Market Insights, Overview, Analysis and Forecast 2022 NeighborWebSJ - NeighborWebSJ - January 23rd, 2021
- Seattle researchers find clues for treatments that could eliminate HIV in infected patients - GeekWire - January 14th, 2021
- Can Retinol and Niacinamide Be Used Together? Here's What the Experts Had to Say - POPSUGAR - January 14th, 2021
- Reversing The Aging Clock With Epigenetic Reprogramming - Bio-IT World - January 14th, 2021
- Bath And Body Routines That Make You Look And Feel Good From Day To Night - Forbes - January 12th, 2021
- Worldwide Organ and Tissue Transplantation and Alternatives Industry to 2024 - Featuring Mylan, Novartis & Pfizer Among Others -... - January 12th, 2021
- BENEV Announces Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell- derived Exosomes and Fractional CO2 Laser for Acne... - January 9th, 2021
- Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years - Endpoints News - January 9th, 2021
- Breakthrough Oxygen Therapy Reverses The Aging Process - happi.com - January 9th, 2021
- Ulta Beautys Love Your Skin Event Is Here | January 2021 - Allure - January 9th, 2021
- Exosome Therapeutic Market Overview By Size, Share, Trends, Growth Factors and Leading Players With Detailed Analysis of Industry Structure - KSU |... - January 9th, 2021
- The real reason behind goosebumps - Jill Lopez - January 5th, 2021
- The Complete Guide to Laser Treatments for Hair and Skin | The Science of Beauty Podcast | Allure - Allure - January 5th, 2021
- The facts about the danger of melanoma - The Hudson Reporter - December 19th, 2020
- The Adrenomyeloneuropathy Treatment Market to grow on an emphatic note from 2019 to 2029 - PharmiWeb.com - December 19th, 2020
- At 14.6% CAGR, Cell Banking Outsourcing Market 2020 Industry Analysis of Current Trends and Opportun - PharmiWeb.com - December 19th, 2020
- TruSkin Dropped a Holiday Bundle Including Its Vitamin C Serum - InStyle - December 19th, 2020
- COVID-19 and graft-versus-host disease: a tale of two diseases (and why age matters) - DocWire News - December 11th, 2020
- Avenoir Cosmetics Launches Cell Repair Serum - Clinical Strength to Enhance Skin Tone & Minimize Appearance of Sunspots, Blemishes, Discoloration,... - December 11th, 2020
- CBD: the beauty ingredient trend that can't be stopped - CosmeticsDesign.com USA - December 11th, 2020
- How to Minimize Inflammation and Prevent Your Skin from Inflammaging - Coveteur - December 9th, 2020
- City of Hope Doctors Present Innovative Therapies to Better Treat Blood Cancers at American Society of Hematology Virtual Conference - BioSpace - December 9th, 2020
- Skincare Tips: Expert Shares Facts About Ageing Of Skin That You Must Know - NDTV Doctor - December 9th, 2020
- Reversing vision loss by turning back the aging clock - FierceBiotech - December 9th, 2020
- Constantly Growing Applications and Innovations to Push Sales of Amniotic Membrane Market Up To ~US$2.4 Bn by 2027, Observes TMR - PRNewswire - December 9th, 2020
- Advanced Therapy Medicinal Products Market 2019 Global Industry Analysis By Size, Share, Trends and - PharmiWeb.com - December 9th, 2020
- Europe Tissue Engineering Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Material Type, Applications, and Country -... - December 9th, 2020
- The Medical Skin Care Products Market to witness non-linear transition from 2017 to 2025 - PRnews Leader - November 5th, 2020
- Research providing better understand of graying hair | Health - Galveston County Daily News - November 5th, 2020
- 'We're truly blood brothers': Stanford coach David Shaw and his recent fight to save his brother, Eric - KGO-TV - November 5th, 2020
- Global Anti-Ageing Drugs Market (2020) to Witness Huge Growth by 2026 | La Roche-Posay, Revision Optics, Calico, Nu Skin, L'ORAL, Unity Biotechnology,... - November 5th, 2020
- From Tattoo Balms to Bronzer, Heres What to Buy From the Best Musician-Backed Beauty Brands - Rolling Stone - November 5th, 2020
- APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an Off-the-Shelf Allogeneic Stem Cell Product for the Treatment of... - November 1st, 2020
- The Medical Skin Care Products market to grow on a prudent note from 2017 to 2025 - TechnoWeekly - November 1st, 2020
- You Can Influence The Way Your Skin AgesHere's How - Tatler Singapore - November 1st, 2020
- Global Growth Trends and Competitive Analysis of Skin Care Cosmetic Research Report from 2020-2026 - KYT24 - November 1st, 2020
- Cell Harvesting Systems Market: Increasing demand for stem cell transplantation along with stem cell-based therapy to drive the market - BioSpace - October 28th, 2020
- The Medical Skin Care Products market to witness non-linear transition from 2017 to 2025 - Eurowire - October 28th, 2020
- Rejuvenating Austin spa puts holistic health and wellness on the table - CultureMap Austin - October 28th, 2020
- Impact Of Covid-19 on Cosmetic Skin Care Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - PRnews Leader - October 28th, 2020
- Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBios Demo Day - TechCrunch - October 28th, 2020
- Augustinus Bader on his revolutionary approach to skincare - Wallpaper* - October 23rd, 2020
- 8 Skin-Boosting, Anti-Aging Treatments for Generation Xers and Beyond - NewBeauty Magazine - October 23rd, 2020
- 22 Best Night Creams 2020 for All Skin Types and Concerns - Greatist - October 23rd, 2020
- How Clinique La Prairie Is Keeping Humanity Fashionably Healthy In The Age Of Covid - Forbes - October 23rd, 2020
- New research reveals why low oxygen damages the brain - Science Codex - October 22nd, 2020
- Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapys impact on tissue growth -... - October 22nd, 2020
- Cosmetic Skin Care Market (Covid 19 Impact Analysis) Data Highlighting Major Vendors, Promising Regions, Anticipated Growth Forecast To 2027 -... - October 22nd, 2020
- Biotechs longevity obsession reaches the beauty industry - Glossy - October 22nd, 2020
- Stem cells are believed to play a key role in hair loss - FLWL News - October 13th, 2020
- Brain organoids reveal neuronal flaws in syndrome tied to autism - Spectrum - October 13th, 2020
- Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV (enfortumab vedotin-ejfv) in... - October 13th, 2020
- AIVITA Biomedical's Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Science - PRNewswire - October 10th, 2020
- U of T's Medicine by Design invests $1 million to advance new ideas in regenerative medicine - News@UofT - October 10th, 2020
- Discover The Augustinus Bader Wonder Cream Loved By The A List - Grazia - October 10th, 2020
- Gray Hair: What You Need to Know about Causes and Possible Prevention - Coveteur - October 10th, 2020
- SGEN: The 3 Top Biotech Stocks That Hedge Fund Managers LOVE - StockNews.com - October 10th, 2020
- Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory... - October 7th, 2020